These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 18641033

  • 1. Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.
    Rodríguez-Baño J, López-Cerero L, Navarro MD, Díaz de Alba P, Pascual A.
    J Antimicrob Chemother; 2008 Nov; 62(5):1142-9. PubMed ID: 18641033
    [Abstract] [Full Text] [Related]

  • 2. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.
    Calbo E, Romaní V, Xercavins M, Gómez L, Vidal CG, Quintana S, Vila J, Garau J.
    J Antimicrob Chemother; 2006 Apr; 57(4):780-3. PubMed ID: 16492721
    [Abstract] [Full Text] [Related]

  • 4. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [Abstract] [Full Text] [Related]

  • 5. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.
    Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, Perea EJ, Pérez-Cano R, Hernández JR, Pascual A.
    Clin Infect Dis; 2006 Jan 01; 42(1):37-45. PubMed ID: 16323089
    [Abstract] [Full Text] [Related]

  • 6. Intrafamilial transmission of extended-spectrum-beta-lactamase-producing Escherichia coli and Salmonella enterica Babelsberg among the families of internationally adopted children.
    Tandé D, Boisramé-Gastrin S, Münck MR, Héry-Arnaud G, Gouriou S, Jallot N, Nordmann P, Naas T.
    J Antimicrob Chemother; 2010 May 01; 65(5):859-65. PubMed ID: 20233775
    [Abstract] [Full Text] [Related]

  • 7. Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.
    Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A.
    J Antimicrob Chemother; 2009 Apr 01; 63(4):781-4. PubMed ID: 19223299
    [Abstract] [Full Text] [Related]

  • 8. Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome.
    Gudiol C, Calatayud L, Garcia-Vidal C, Lora-Tamayo J, Cisnal M, Duarte R, Arnan M, Marin M, Carratalà J, Gudiol F.
    J Antimicrob Chemother; 2010 Feb 01; 65(2):333-41. PubMed ID: 19959544
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of rectal carriage of extended-spectrum beta-lactamase-producing Escherichia coli among elderly people in community settings in China.
    Tian SF, Chen BY, Chu YZ, Wang S.
    Can J Microbiol; 2008 Sep 01; 54(9):781-5. PubMed ID: 18772941
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections.
    Azap OK, Arslan H, Serefhanoğlu K, Colakoğlu S, Erdoğan H, Timurkaynak F, Senger SS.
    Clin Microbiol Infect; 2010 Feb 01; 16(2):147-51. PubMed ID: 19689464
    [Abstract] [Full Text] [Related]

  • 11. 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum β-lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre.
    Nicolas-Chanoine MH, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V.
    J Antimicrob Chemother; 2013 Mar 01; 68(3):562-8. PubMed ID: 23143897
    [Abstract] [Full Text] [Related]

  • 12. CTX-M-producing Escherichia coli in a maternity ward: a likely community importation and evidence of mother-to-neonate transmission.
    Dubois V, De Barbeyrac B, Rogues AM, Arpin C, Coulange L, Andre C, M'zali F, Megraud F, Quentin C.
    J Antimicrob Chemother; 2010 Jul 01; 65(7):1368-71. PubMed ID: 20466850
    [Abstract] [Full Text] [Related]

  • 13. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J, Orden B, Bautista V, Cuevas O, Arroyo M, Martínez-Ruiz R, Pérez-Vázquez M, Alcaraz M, García-Cobos S, Campos J.
    J Antimicrob Chemother; 2009 Oct 01; 64(4):712-7. PubMed ID: 19671590
    [Abstract] [Full Text] [Related]

  • 14. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y.
    J Antimicrob Chemother; 2009 Jan 01; 63(1):72-9. PubMed ID: 19004839
    [Abstract] [Full Text] [Related]

  • 15. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
    Rooney PJ, O'Leary MC, Loughrey AC, McCalmont M, Smyth B, Donaghy P, Badri M, Woodford N, Karisik E, Livermore DM.
    J Antimicrob Chemother; 2009 Sep 01; 64(3):635-41. PubMed ID: 19549667
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).
    J Antimicrob Chemother; 2010 Mar 01; 65(3):465-9. PubMed ID: 20053690
    [Abstract] [Full Text] [Related]

  • 17. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z, Afacan G, Nicolas-Chanoine MH, Sotto A, Lavigne JP.
    J Antimicrob Chemother; 2008 Aug 01; 62(2):284-8. PubMed ID: 18453527
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
    Heffernan HM, Woodhouse RE, Pope CE, Blackmore TK.
    Int J Antimicrob Agents; 2009 Dec 01; 34(6):544-9. PubMed ID: 19748232
    [Abstract] [Full Text] [Related]

  • 19. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France.
    Leflon-Guibout V, Blanco J, Amaqdouf K, Mora A, Guize L, Nicolas-Chanoine MH.
    J Clin Microbiol; 2008 Dec 01; 46(12):3900-5. PubMed ID: 18842941
    [Abstract] [Full Text] [Related]

  • 20. Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.
    Miró E, Mirelis B, Navarro F, Rivera A, Mesa RJ, Roig MC, Gómez L, Coll P.
    J Antimicrob Chemother; 2005 Dec 01; 56(6):1152-5. PubMed ID: 16244084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.